Daxas Approved In EU With Narrow Indication
Nycomed's drug gets the green light to treat severe COPD with chronic bronchitis in adult patients with a history of frequent exacerbations, as an add-on to bronchodilator treatment.
Nycomed's drug gets the green light to treat severe COPD with chronic bronchitis in adult patients with a history of frequent exacerbations, as an add-on to bronchodilator treatment.